Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2025-12-25 @ 2:21 AM
NCT ID:
NCT02744534
Eligibility Criteria:
Inclusion Criteria:
* Have been originally diagnosed with prostate carcinoma and have undergone definitive non-prostatectomy therapy for localized disease
* There is suspicion of recurrent prostate carcinoma as defined by: Older American Society for Radiation Oncology (ASTRO) criteria of three consecutive rises of prostate-specific antigen (PSA) or earlier if clinically appropriate, and/or nadir + 2.0 ng/ml (Radiation Therapy Oncology Group (RTOG)-ASTRO Phoenix criteria)
* Able to provide written informed consent
Exclusion Criteria:
* Cryotherapy, external beam radiation, or high intensity focused ultrasound (HIFU) within the past year
* Brachytherapy within the past two years (to rule out a transient rise in PSA)
* Prostate biopsy within the past month (to decrease a false positive result due to inflammation)
* Not otherwise eligible for prostate biopsy
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT02744534
Study Brief:
Protocol Section:
NCT02744534